Company Name: Reata Pharmaceuticals, Inc.     

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company.  The company is engaged in the development of drugs designed to modulate the activity of transcription factors. The company’s developmental pipeline includes product candidates in a several areas including cardiovascular, immune-oncology, ophthalmology and rare diseases.

Ticker Symbol: RETA (NASDAQ)

Company Website:

Social Media:

Reata Pharmaceuticals LinkedIn

Reata Pharmaceuticals Twitter

Headquarters: Irving, Texas